Tasigna Stroke Lawsuit Filed Over Side Effects of CML Treatment
A Tasigna lawsuit claims the side effects of the CML drug caused a woman to suffer a stroke due to a blocked carotid artery.
Tag Archives: Chronic Myeloid Leukemia
-
-
Tasigna Wrongful Death Lawsuit Filed Over Atherosclerotic-Related Injuries
A Tasigna wrongful death lawsuit claims a New Jersey man's mother died of a heart attack after the CML drug caused her to develop coronary artery disease and other ailments.
-
Tasigna Lawsuit Filed Over Arterial Occlusive Disease Injuries
A Tasigna lawsuit filed by an Ohio woman claims the company failed to warn consumers of the drug's artery-hardening effects in order to maximize profits.
-
Tasigna Injury Claims Consolidated in New Jersey Multicounty Litigation (MCL)
All Tasigna lawsuits filed in New Jersey state courts have been consolidated before one judge for pretrial proceedings.
-
Tasigna Heart Attack Lawsuit Filed Over Side Effects of Chemotherapy Drug
A Tasigna lawsuit claims a woman suffered a heart attack and other complications due to the side effects of the CML drug.
-
Lawsuit Alleges Tasigna Caused Loss of Blood Flow To The Spleen
A Tasigna lawsuit claims the side effects of the leukemia drug led to a loss of blood flow to a man's spleen, resulting in the need to have it removed.
-
Novartis Concealed Information About Tasigna Problems, Resulting In Toe Amputations, Lawsuit Alleges
A Kentucky woman says she had to undergo multiple toe amputations because of Novartis's failure to provide adequate warning labels to Tasigna, a leukemia drug.
-
Tasigna Side Effects Cause Narrowing and Hardening of Arteries, Stroke: Lawsuit
A Tasigna product liability lawsuit indicates a Virginia man suffered coronary artery disease, peripheral vascular disease and a stroke after using the leukemia drug.
-
Centralization of Tasigna Lawsuits Requested in New Jersey Multi-County Litigation (MCL)
Plaintiffs are asking the New Jersey Supreme Court to consolidate all Tasigna lawsuits filed in that state before one judge for pretrial proceedings.
-
Despite Artery Concerns, FDA Approves Tasigna For Use By Children
The FDA has approved the use of the leukemia drug Tasigna for children, despite recent concerns that it could cause artery hardening and thickening.
